Pennington Biomedical Research Center, Baton Rouge, LA, USA.
Louisiana State University Health Sciences Center New Orleans School of Medicine, New Orleans, LA, USA.
JNCI Cancer Spectr. 2024 Jul 1;8(4). doi: 10.1093/jncics/pkae058.
The decline of physical function during chemotherapy predicts poor quality of life and premature death. It is unknown if resistance training prevents physical function decline during chemotherapy in colon cancer survivors.
This multicenter trial randomly assigned 181 colon cancer survivors receiving postoperative chemotherapy to home-based resistance training or usual care control. Physical function outcomes included the short physical performance battery, isometric handgrip strength, and the physical function subscale of the Medical Outcomes Short-Form 36-item questionnaire. Mixed models for repeated measures quantified estimated treatment differences.
At baseline, participants had a mean (SD) age of 55.2 (12.8) years; 67 (37%) were 60 years or older, and 29 (16%) had a composite short physical performance battery score of no more than 9. Compared with usual care control, resistance training did not improve the composite short physical performance battery score (estimated treatment difference = -0.01, 95% confidence interval [CI] = -0.32 to 0.31; P = .98) or the short physical performance battery scores for balance (estimated treatment difference = 0.01, 95% CI = -0.10 to 0.11; P = .93), gait speed (estimated treatment difference = 0.08, 95% CI = -0.06 to 0.22; P = .28), and sit-to-stand (estimated treatment difference = -0.08, 95% CI = -0.29 to 0.13; P = .46). Compared with usual care control, resistance training did not improve isometric handgrip strength (estimated treatment difference = 1.50 kg, 95% CI = -1.06 to 4.05; P = .25) or self-reported physical function (estimated treatment difference = -3.55, 95% CI = -10.03 to 2.94); P = .28). The baseline short physical performance battery balance score (r = 0.21, 95% CI = 0.07 to 0.35) and handgrip strength (r = 0.23, 95% CI = 0.09 to 0.36) correlated with chemotherapy relative dose intensity.
Among colon cancer survivors with relatively high physical functioning, random assignment to home-based resistance training did not prevent physical function decline during chemotherapy.
NCT03291951.
化疗期间身体功能下降预示着生活质量较差和过早死亡。目前尚不清楚抗阻力训练是否能预防结肠癌幸存者在化疗期间身体功能下降。
这项多中心试验将 181 名接受术后化疗的结肠癌幸存者随机分配至家庭抗阻力训练或常规护理对照组。身体功能的评估结果包括短体适能测试、握力测试和 36 项简明健康调查简表的身体功能子量表。重复测量混合模型定量估计了治疗差异。
在基线时,参与者的平均(标准差)年龄为 55.2(12.8)岁;67 人(37%)为 60 岁或以上,29 人(16%)的短体适能测试综合评分为不超过 9 分。与常规护理对照组相比,抗阻力训练并未改善短体适能测试综合评分(估计治疗差异=-0.01,95%置信区间[CI]为-0.32 至 0.31;P=0.98)或短体适能测试的平衡评分(估计治疗差异=0.01,95%CI 为-0.10 至 0.11;P=0.93)、步态速度评分(估计治疗差异=0.08,95%CI 为-0.06 至 0.22;P=0.28)和从座位站起评分(估计治疗差异=-0.08,95%CI 为-0.29 至 0.13;P=0.46)。与常规护理对照组相比,抗阻力训练也没有改善握力(估计治疗差异=1.50 千克,95%CI 为-1.06 至 4.05;P=0.25)或自我报告的身体功能(估计治疗差异=-3.55,95%CI 为-10.03 至 2.94;P=0.28)。基线短体适能测试平衡评分(r=0.21,95%CI 为 0.07 至 0.35)和握力(r=0.23,95%CI 为 0.09 至 0.36)与化疗相对剂量强度相关。
在身体功能相对较高的结肠癌幸存者中,随机分配至家庭抗阻力训练并未预防化疗期间身体功能下降。
NCT03291951。